0001662244-16-000003.txt : 20161116
0001662244-16-000003.hdr.sgml : 20161116
20161116112637
ACCESSION NUMBER: 0001662244-16-000003
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20161116
DATE AS OF CHANGE: 20161116
EFFECTIVENESS DATE: 20161116
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662244
IRS NUMBER: 455429901
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-254143
FILM NUMBER: 162001716
BUSINESS ADDRESS:
STREET 1: 763E CONCORD AVENUE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: 617-248-5239
MAIL ADDRESS:
STREET 1: 763E CONCORD AVENUE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001662244
Cyteir Therapeutics, Inc.
763E CONCORD AVENUE
CAMBRIDGE
MA
MASSACHUSETTS
02138
617-248-5239
DELAWARE
None
None
Corporation
true
2012
Donald
Corcoran
c/o Cyteir Therapeutics, Inc.
763E Concord Avenue
Cambridge
MA
MASSACHUSETTS
02138
Executive Officer
Director
Kevin
Mills
c/o Cyteir Therapeutics, Inc.
763E Concord Avenue
Cambridge
MA
MASSACHUSETTS
02138
Executive Officer
Director
Ronald
Goldstein
c/o Cyteir Therapeutics, Inc.
763E Concord Avenue
Cambridge
MA
MASSACHUSETTS
02138
Executive Officer
Timothy
Romberger
c/o Cyteir Therapeutics, Inc.
763E Concord Avenue
Cambridge
MA
MASSACHUSETTS
02138
Director
Barry
Mills
c/o Cyteir Therapeutics, Inc.
763E Concord Avenue
Cambridge
MA
MASSACHUSETTS
02138
Director
Markus
Renschler
c/o Cyteir Therapeutics, Inc.
763E Concord Avenue
Cambridge
MA
MASSACHUSETTS
02138
Director
Other Health Care
Decline to Disclose
- 06b
true
0001662244-15-000001
2015-10-27
false
true
true
false
0
5817996
5817996
0
false
15
0
0
0
false
Cyteir Therapeutics, Inc.
/s/ Donald Corcoran
Donald Corcoran
President and CEO
2016-11-15